Skip to main content
. 2020 Oct 23;10(10):106. doi: 10.1038/s41408-020-00369-0

Fig. 3. Duration of response (A) and progression-free survival (B) full analysis population.

Fig. 3

Responses were assessed by an independent review committee according to International Myeloma Working Group criteria20.